CITIC Securities: Short-term white horse style may be dominated by stages due to compensatory growth and repair. CITIC Securities Research Report pointed out that looking forward to 2025, we expect that the market style will gradually switch from individual investors to institutional investors, and ETF will become an important configuration tool. We believe that the construction of ETF portfolio should mainly depend on the judgment of style rotation and timing. We believe that in the short term, Politburo meeting of the Chinese Communist Party and the Central Economic Work Conference will once again confirm the policy inflection point, which is expected to boost institutional investors' risk appetite, and the white horse style may prevail in stages due to compensatory growth and repair. However, in the large-cycle environment, it is still unable to meet the conditions for the continued dominance of white horse stocks, and it is necessary to continue to observe the price signals and policies.The market demand for large-size OLEDs has significantly improved, and the industrial chain has made great efforts to break through bottlenecks such as materials. According to the Securities Daily, on December 12th, Huawei Technologies Co., Ltd. officially launched the new MatePad Pro, which uses a 13.2-inch large-size flexible OLED screen. "In recent years, the application scenarios of OLED screens have become more and more extensive, especially the application of large-size OLED screens has shown a rapid growth trend, which will drive the relevant needs of the industrial chain." Ding Bingzhong, a partner of Shanghai Jimao Asset Management Co., Ltd., said in an interview. In the industry's view, the shipments of large-size OLED panels are rising, mainly due to the growing demand for artificial intelligence, games and high-end laptops. The continuous expansion of large-size OLED applications will also drive the demand for OLED materials to increase. "It should be noted that at present, China's OLED materials have not been fully localized, especially the localization rate of terminal materials is still relatively low." Ding Bingzhong said.In the first 11 months of GEM, the scale of raising funds by issuing 34 new shares dropped significantly year-on-year. Statistics show that from January to November, 2024, there were 34 new shares listed on GEM, with a total amount of raised funds of about 20.174 billion yuan. The number of issues and the scale of raising funds decreased by about 67% and 83% respectively year-on-year, and the number of listed new shares declined for three consecutive years. Among them, Nova Nebula and Yilian Technology have raised a total of more than 1 billion yuan, which is on the top. The share prices of the first-time shares of GEM all rose on the first day of listing, among which Changlian Technology and Shangda Shares rose more than 1000% on the first day of listing. In addition, there are 17 new shares listed income increased by more than 200%. In terms of underwriters, in the first November of 2024, the number of main underwriting projects of CITIC Jiantou, Guotai Junan and CICC was in the top three. Judging from the scale of fundraising, the total number of projects underwritten by Minsheng Securities and CITIC Jiantou exceeds 2.5 billion yuan, and the project scale of China Merchants Securities, Huatai United Securities and Guotai Junan exceeds 1.5 billion yuan. (Xinhua Finance)
The restricted shares with a market value of 644 million yuan were lifted today. Xishan Technology, Betray and Wanda Bearing were among the top companies in terms of market value. On Friday (December 13th), the restricted shares of eight companies were lifted, with a total lifting amount of 20,925,400 shares. According to the latest closing price, the total lifting market value was 644 million yuan. Judging from the amount of lifting the ban, Betray, Xishan Technology and Nanwang Technology were among the top, with 9,834,300 shares, 3,706,800 shares and 3,247,500 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by 0 companies exceeded 100 million yuan. Xishan Technology, Betray and Wanda Bearing are among the top companies in terms of market value, with market values of 246 million yuan, 229 million yuan and 76.73 million yuan respectively. From the perspective of the proportion of shares released from the ban to the total share capital, Xishan Technology, Wanda Bearing and Nanwang Technology are among the top, with 7.47%, 3.08% and 1.66% respectively.Ministry of National Defense: Fujian Ship will gradually launch the follow-up test project. On the morning of December 13th, Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, released a message on the recent military-related issues. Reporter: According to the announcement of Shanghai Maritime Safety Administration, in early December, traffic control was implemented for the import of a large ship in the deep water channel of the Yangtze River estuary. Some analysts believe that China Navy Fujian Ship may have completed its fifth sea trial and returned to its home port. Can you confirm it? Wu Qian: It is a normal arrangement for Fujian Ship to carry out relevant tests during the construction process. In the next step, follow-up test projects will be gradually launched according to the progress of aircraft carrier construction. (issued by the Ministry of National Defense)Bank of Japan: Japanese companies expect consumer prices to rise by 2.3% in three years, compared with 2.3% in the previous survey; Japanese companies expect consumer prices to rise by 2.2% in five years, compared with 2.2% in the last survey.
Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.Citic Jiantou Pharmaceutical's 2025 strategy: looking for new additions and integration opportunities. Citic Jiantou said that looking forward to 2025, the reform policy in the medical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations as a whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.Bank of Japan: Japanese companies expect consumer prices to rise by 2.3% in three years, compared with 2.3% in the previous survey; Japanese companies expect consumer prices to rise by 2.2% in five years, compared with 2.2% in the last survey.
Strategy guide
12-14
Strategy guide